Cargando…
Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques
Recombinant antibodies play increasingly important roles as immunotherapeutic treatments for human cancers as well as inflammatory and infectious diseases and have revolutionized their management. In addition, their therapeutic potential may be enhanced by the introduction of defined mutations in th...
Autores principales: | Rosenberg, Yvonne J., Lewis, George K., Montefiori, David C., LaBranche, Celia C., Lewis, Mark G., Urban, Lori A., Lees, Jonathan P., Mao, Lingjun, Jiang, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437720/ https://www.ncbi.nlm.nih.gov/pubmed/30785963 http://dx.doi.org/10.1371/journal.pone.0212649 |
Ejemplares similares
-
Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
por: Rosenberg, Yvonne J., et al.
Publicado: (2016) -
To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1
por: Griffith, Sarah A., et al.
Publicado: (2021) -
Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs
por: Seaman, Michael S., et al.
Publicado: (2020) -
Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
por: Rosenberg, Yvonne, et al.
Publicado: (2015) -
Understanding the Determinants of BnAb Induction in Acute HCV Infection
por: Underwood, Alexander P., et al.
Publicado: (2018)